Streetbeat News

Stock Prices

DOGEUSD

ETHUSD

PEPEUSD

SHIBUSD

Glauber Contessoto, known as the 'Dogecoin Millionaire,' has invested $100,000 in the Ethereum-based meme coin Neiro (NEIRO). He believes NEIRO has the potential to replicate the success of Dogecoin and Shiba Inu due to its high market cap, strong community support, and user-friendly nature on the Ethereum blockchain.

Portfolio Pulse from Khyathi Dalal

August 07, 2024 | 2:09 pm

DT

Dynatrace, Inc. (NYSE:DT) shares surged 15.5% after reporting better-than-expected Q1 2025 results. The company posted a 20% YoY revenue growth to $399.22 million, beating the consensus of $391.758 million. Adjusted EPS was $0.33, surpassing the estimate of $0.29. ARR increased by 19% YoY, and subscription revenues rose 21% YoY. The company also repurchased 1.1 million shares for $50 million. Dynatrace reaffirmed its 2025 outlook with expected revenue of $1.644 billion – $1.658 billion and adjusted EPS of $1.26 – $1.29.

Portfolio Pulse from Akanksha Bakshi

August 07, 2024 | 2:09 pm

INSP

Inspire Medical Systems shares are trading higher following better-than-expected Q2 sales results and an increase in FY24 guidance. The company also announced a $150 million share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 2:07 pm

TECH

Bio-Techne shares are trading lower after the company reported worse-than-expected Q4 revenue results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 2:07 pm

CRL

Charles River Laboratories (NYSE: CRL) reported a 3.2% year-over-year revenue decline for Q2 2024, beating the consensus estimate. Despite an increase in adjusted EPS, the company lowered its revenue and EPS guidance for 2024 due to a continued slump in biotech demand. The stock fell 12.6% following the announcement.

Portfolio Pulse from Vandana Singh

August 07, 2024 | 2:06 pm

AAPL

AMZN

BTCUSD

INTC

META

NVDA

This week in investing, President Trump discusses a Bitcoin strategic reserve, tech stocks face another tough week, and macroeconomic data suggests a rate cut by the Federal Reserve in September. Intel's poor earnings report stands out, while the Bank of England cuts rates and the Bank of Japan raises them. The Magnificent 7 tech stocks, including Meta, Apple, Amazon, and Nvidia, continue to struggle despite mixed earnings results.

Portfolio Pulse from Gary Brode

August 07, 2024 | 2:06 pm

AMGN

Amgen Inc. (NASDAQ:AMGN) reported strong Q2 sales growth of 20% year-over-year, driven by a 26% increase in volume. Despite missing EPS expectations, the company raised its 2024 guidance. William Blair sees significant upside potential for Amgen, particularly with its pipeline assets like MariTide, Imdelltra, and rocatinlimab. Near-term challenges include upcoming biosimilar launches and market share struggles. The stock was down 4.99% at $312.80.

Portfolio Pulse from Vandana Singh

August 07, 2024 | 2:06 pm

JPM

Investors with significant capital have taken a mixed stance on JPMorgan Chase (NYSE:JPM), with 50% bullish and 50% bearish sentiment observed in recent options trades. The predicted price range for JPM is between $200.0 and $215.0 over the next three months. Analysts have given mixed ratings, with target prices ranging from $211 to $225.

Portfolio Pulse from Benzinga Insights

August 07, 2024 | 2:01 pm

VECO

Analysts have provided diverse evaluations of Veeco Instruments (NASDAQ:VECO) over the past three months, with a mix of bullish, somewhat bullish, and indifferent ratings. The average 12-month price target has increased to $51.25, reflecting a 10.81% rise from the previous target. Key analysts from Needham, Citigroup, and Oppenheimer have maintained or raised their ratings and price targets, indicating positive sentiment towards the company's future performance.

Portfolio Pulse from Benzinga Insights

August 07, 2024 | 2:01 pm

CVNA

Financial giants are making significant bearish moves on Carvana (NYSE:CVNA) through options trading. Analysis reveals 65% of trades are bearish, with a focus on a price range between $25.0 and $140.0. Current trading volume is 458,526, with the stock price down by -1.08% to $137.45. Analysts have mixed ratings, with target prices ranging from $110 to $200.

Portfolio Pulse from Benzinga Insights

August 07, 2024 | 2:01 pm